首页> 外文OA文献 >Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in 'non-tubular' renal disease.
【2h】

Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in 'non-tubular' renal disease.

机译:β2-糖蛋白-1(载脂蛋白H)的尿排泄和“非肾小管”肾病中肾小管功能障碍的其他标志物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To determine whether urinary beta 2-glycoprotein-1 assays can provide improved discrimination between chronic renal diseases which are primarily of tubular or glomerular origin. METHODS: Urinary beta 2-glycoprotein-1, retinol-binding protein, alpha 1-microglobulin, beta 2-microglobulin, N-acetyl-beta-D-glucosa-minidase and albumin were measured in 51 patients with primary glomerular disease, 23 with obstructive nephropathy, and 15 with polycystic kidney disease, and expressed per mmol of creatinine. Plasma beta 2-glycoprotein-1 was assayed in 52 patients and plasma creatinine in all 89. The findings were compared between the diagnostic groups and with previously published data relating to primary tubular disorders. RESULTS: All 31 patients with plasma creatinine greater than 200 mumol/l excreted increased amounts of beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin, and 29 had increased N-acetyl-beta-D-glucosaminidase; the quantities were generally similar to those found in comparable patients with primary tubular pathology. Among 58 with plasma creatinine concentrations under 200 mumol/l, increases in beta 2-glycoprotein-1, retinol-binding protein, and alpha 1-microglobulin excretion were less common and much smaller, especially in those with obstructive nephropathy and polycystic disease. The ratios of the excretion of albumin to the other proteins provided the clearest discrimination between the patients with glomerular or tubular malfunction, but an area of overlap was present which embraced those with obstructive nephropathy and polycystic disease. CONCLUSIONS: Increased excretion of beta 2-glycoprotein-1 due to a raised plasma concentration or diminution of tubular reabsorption, or both, is common in all the forms of renal disease investigated, and both plasma creatinine and urinary albumin must be taken into account when interpreting results. Ratios of urinary albumin: beta 2-glycoprotein-1 greater than 1000 are highly suggestive of primary glomerular disease and those less than 40 of primary tubular disease. Used in this way, beta 2-glycoprotein-1 assays provide superior discrimination between glomerular and tubular malfunction when compared with retinol binding protein but the best discrimination is provided by albumin: alpha 1-microglobulin ratios.
机译:目的:确定尿β2-糖蛋白-1检测法是否可以改善主要是肾小管或肾小球起源的慢性肾脏疾病之间的区别。方法:对51例原发性肾小球疾病患者中的尿β2-糖蛋白-1,视黄醇结合蛋白,α1-微球蛋白,β2-微球蛋白,N-乙酰基-β-D-葡糖苷酶和白蛋白进行了测定,其中23例伴有肾小球疾病。阻塞性肾病和15例多囊肾,并以每毫摩尔肌酐表示。对52例患者的血浆β2-糖蛋白-1进行了测定,对所有89例患者的血浆肌酐进行了测定。将这些发现与诊断组以及以前发表的有关原发性肾小管疾病的数据进行了比较。结果:31例血浆肌酐大于200μmol/ l的患者排泄了β2-糖蛋白-1,视黄醇结合蛋白和α1-微球蛋白的增加,其中29例N-乙酰基-β-D-氨基葡萄糖苷酶增加。该数量通常与可比的原发性肾小管病理​​学患者的数量相似。在血浆肌酐浓度低于200摩尔/升的58例患者中,β2-糖蛋白-1,视黄醇结合蛋白和α1-微球蛋白排泄的增加较少见,而且更小,特别是在患有阻塞性肾病和多囊性疾病的患者中。白蛋白与其他蛋白的排泄率在肾小球或肾小管功能不全患者之间提供了最清晰的区分,但存在重叠区域,包括患有阻塞性肾病和多囊性疾病的患者。结论:由于血浆浓度升高或肾小管重吸收减少或两者兼而有之,β2-糖蛋白-1的排泄增加在所研究的所有肾脏疾病中都是常见的,并且何时应同时考虑血浆肌酐和尿白蛋白。解释结果。尿白蛋白:β2-糖蛋白-1的比例大于1000时,强烈提示原发性肾小球疾病,而小于40%的则提示原发性肾小球疾病。以这种方式使用时,与视黄醇结合蛋白相比,β2-糖蛋白1测定法可更好地区分肾小球和肾小管功能障碍,但最好的区分是白蛋白:α1-微球蛋白比率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号